Daniel C. DeSimone

3.2k total citations
122 papers, 1.7k citations indexed

About

Daniel C. DeSimone is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel C. DeSimone has authored 122 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Epidemiology, 53 papers in Infectious Diseases and 48 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel C. DeSimone's work include Infective Endocarditis Diagnosis and Management (82 papers), Antimicrobial Resistance in Staphylococcus (36 papers) and Cardiac pacing and defibrillation studies (27 papers). Daniel C. DeSimone is often cited by papers focused on Infective Endocarditis Diagnosis and Management (82 papers), Antimicrobial Resistance in Staphylococcus (36 papers) and Cardiac pacing and defibrillation studies (27 papers). Daniel C. DeSimone collaborates with scholars based in United States, Saudi Arabia and United Kingdom. Daniel C. DeSimone's co-authors include Larry M. Baddour, M. Rizwan Sohail, Nandan S. Anavekar, Walter R. Wilson, James M. Steckelberg, Brian D. Lahr, Bernard J. Gersh, Imad M. Tleyjeh, Scott Hubers and Daniel D. Correa de and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Daniel C. DeSimone

104 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel C. DeSimone United States 21 1.1k 611 567 451 430 122 1.7k
María Carmen Fariñas Spain 25 1.1k 0.9× 645 1.1× 264 0.5× 261 0.6× 499 1.2× 104 2.0k
Juan Gálvez-Acebal Spain 21 1.0k 0.9× 644 1.1× 320 0.6× 360 0.8× 371 0.9× 59 1.5k
Gail Peterson United States 20 1.2k 1.0× 622 1.0× 674 1.2× 524 1.2× 367 0.9× 34 1.7k
Enrique Navas Spain 24 1.0k 0.9× 821 1.3× 221 0.4× 338 0.7× 306 0.7× 80 1.7k
Leo J. Gerards Netherlands 26 872 0.8× 505 0.8× 240 0.4× 757 1.7× 248 0.6× 53 1.8k
Athanasios Michos Greece 22 524 0.5× 643 1.1× 149 0.3× 233 0.5× 200 0.5× 98 1.4k
C. Strady France 15 666 0.6× 453 0.7× 137 0.2× 314 0.7× 317 0.7× 44 1.2k
Gregory M. Caputo United States 19 580 0.5× 412 0.7× 105 0.2× 329 0.7× 439 1.0× 41 2.3k
Mervyn Shapiro Israel 24 602 0.5× 397 0.6× 134 0.2× 278 0.6× 496 1.2× 53 1.6k
Romain Basmaci France 19 471 0.4× 558 0.9× 88 0.2× 447 1.0× 924 2.1× 53 1.8k

Countries citing papers authored by Daniel C. DeSimone

Since Specialization
Citations

This map shows the geographic impact of Daniel C. DeSimone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. DeSimone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. DeSimone more than expected).

Fields of papers citing papers by Daniel C. DeSimone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. DeSimone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. DeSimone. The network helps show where Daniel C. DeSimone may publish in the future.

Co-authorship network of co-authors of Daniel C. DeSimone

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. DeSimone. A scholar is included among the top collaborators of Daniel C. DeSimone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. DeSimone. Daniel C. DeSimone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chesdachai, Supavit, Daniel C. DeSimone, Nischal Ranganath, & Omar Abu Saleh. (2025). Plasma Quantitative Microbial Cell-Free DNA for Staphylococcal Cardiac Implantable Electronic Device Infection—Too Soon?. Clinical Infectious Diseases. 81(4). e235–e236.
2.
Saleh, Omar Abu, Supavit Chesdachai, Brian D. Lahr, et al.. (2025). Blood Culture Time to Positivity and Risk of Infective Endocarditis. Clinical Infectious Diseases. 81(6). e732–e733.
3.
Yousufuddin, Mohammed, Mohamad H. Yamani, Daniel C. DeSimone, et al.. (2025). In-Hospital Adverse Events in Heart Failure Patients: Incidence and Association with 90-Day Mortality. The Joint Commission Journal on Quality and Patient Safety. 51(6). 423–437. 1 indexed citations
4.
Agarwal, Siddharth, Zain Ul Abideen Asad, Muhammad Bilal Munir, et al.. (2025). Urban‐Rural Differences in the Outcomes of Patients Hospitalized for Cardiac Implantable Electronic Devices Infection in the United States. Journal of Cardiovascular Electrophysiology. 36(5). 1068–1072.
5.
Lahr, Brian D., Supavit Chesdachai, Daniel C. DeSimone, et al.. (2025). Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis. Journal of the American Heart Association. 14(3). e036648–e036648. 3 indexed citations
6.
Chesdachai, Supavit, Larry M. Baddour, Hussam Tabaja, et al.. (2025). Executive Summary: State-of-the-Art Review: Complexities in Cardiac Implantable Electronic Device Infections: A Contemporary Practical Approach. Clinical Infectious Diseases. 80(1). 1–3.
7.
Tabaja, Hussam, Supavit Chesdachai, Aditya Shah, et al.. (2024). Fostering Collaborative Teamwork—A Comprehensive Approach to Vascular Graft Infection Following Arterial Reconstructive Surgery. Clinical Infectious Diseases. 78(6). e69–e80. 1 indexed citations
8.
Haddad, Sara F., Brian D. Lahr, Abdallah El Sabbagh, et al.. (2024). Percutaneous mechanical aspiration in patients with right‐sided infective endocarditis: An analysis of the national inpatient sample database—2016–2020. Catheterization and Cardiovascular Interventions. 103(3). 464–471.
9.
Baddour, Larry M., et al.. (2024). Identification of the Skip Phenomenon Among Patients With Staphylococcus lugdunensis Infective Endocarditis: A Retrospective Review. Open Forum Infectious Diseases. 12(1). ofaf015–ofaf015.
10.
Tabaja, Hussam, Supavit Chesdachai, Aditya Shah, et al.. (2024). Executive Summary: State-of-the-Art Review: Fostering Collaborative Teamwork—A Comprehensive Approach to Vascular Graft Infection Following Arterial Reconstructive Surgery. Clinical Infectious Diseases. 78(6). 1391–1392.
11.
Haddad, Sara F., Brian D. Lahr, Supavit Chesdachai, et al.. (2023). Bloodstream Infection Due to Coagulase-Negative Staphylococci: Impact of Species on Prevalence of Infective Endocarditis. Antibiotics. 12(9). 1453–1453. 5 indexed citations
12.
Wurcel, Alysse G., Daniel C. DeSimone, Laura R. Marks, Larry M. Baddour, & Parham Sendi. (2023). Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder. Clinical Microbiology and Infection. 29(8). 952–954. 3 indexed citations
13.
Haddad, Sara F., Daniel C. DeSimone, Supavit Chesdachai, Dana Gerberi, & Larry M. Baddour. (2022). Utility of Metagenomic Next-Generation Sequencing in Infective Endocarditis: A Systematic Review. Antibiotics. 11(12). 1798–1798. 20 indexed citations
14.
Ward, Robert C., Shiva Ponamgi, Samuel J. Asirvatham, et al.. (2021). Infection Rate and Outcomes of Watchman Devices: Results from a Single-Center 14-Year Experience. SHILAP Revista de lepidopterología. 6(2). 59–62. 3 indexed citations
15.
McHugh, Jack, Khawaja M. Talha, Larry M. Baddour, et al.. (2021). Bloodstream Infection Following Cardiac Valve Repair: A Population-Based Study. Open Forum Infectious Diseases. 8(11). ofab493–ofab493. 1 indexed citations
16.
Miranda, William R., et al.. (2020). Incidence and outcomes of prosthetic valve endocarditis in adults with tetralogy of Fallot. Cardiology in the Young. 30(1). 19–23. 3 indexed citations
17.
DeSimone, Daniel C. & M. Rizwan Sohail. (2018). Infection Management. Cardiac Electrophysiology Clinics. 10(4). 601–607. 6 indexed citations
18.
DeSimone, Daniel C., M. Rizwan Sohail, Holenarasipur R. Vikram, et al.. (2018). Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis. Journal of Infection. 77(5). 398–404. 29 indexed citations
19.
DeSimone, Daniel C., Imad M. Tleyjeh, Daniel D. Correa de, et al.. (2015). Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association’s Prevention Guidelines. Mayo Clinic Proceedings. 90(7). 874–881. 49 indexed citations
20.
DeSimone, Christopher V., Paul A. Friedman, Amit Noheria, et al.. (2013). Stroke or Transient Ischemic Attack in Patients With Transvenous Pacemaker or Defibrillator and Echocardiographically Detected Patent Foramen Ovale. Circulation. 128(13). 1433–1441. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026